10th-Feb-2012 09:50
Source: BSE
GlaxoSmithKline - FY11 results on Feb 16, 2012
GlaxoSmithKline Pharmaceuticals Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on February 16, 2012, inter alia, to consider approval of audited financial result for the year ended December 31, 2011 and to recommend dividend, if any, on the equity shares of the Company.